• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    34843027.pdf
    Size:
    379.5Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Coe, Faye
    Misra, Vivek
    McCabe, Yamini
    Adderley, Helen
    Woodhouse, Laura
    Ayub, Zaheen
    Wang, Xin
    Howell, Sacha J
    Ekholm, Maria
    Affiliation
    Department of Pharmacy, The Christie NHS Foundation Trust, Manchester, UK
    Issue Date
    2021
    
    Metadata
    Show full item record
    Citation
    Coe F, Misra V, McCabe Y, Adderley H, Woodhouse L, Ayub Z, et al. Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021.
    Journal
    Breast Cancer Research and Treatment
    URI
    http://hdl.handle.net/10541/624952
    DOI
    10.1007/s10549-021-06438-7
    PubMed ID
    34843027
    Type
    Article
    ae974a485f413a2113503eed53cd6c53
    10.1007/s10549-021-06438-7
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer.
    • Authors: Chabot I, Zhao Q, Su Y
    • Issue date: 2020 Dec
    • Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort study.
    • Authors: Ni M, Zhou L, Lu Y, Guo D, Li X, Li L, Zhang L, Chen M, Zhang L, Xu F, Yuan Z, Wang S, Shi Y, Yang A, An X
    • Issue date: 2024 Sep 30
    • Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States.
    • Authors: Mougalian SS, Kish JK, Zhang J, Liassou D, Feinberg BA
    • Issue date: 2021 May
    • Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
    • Authors: Oruc Z, Kaplan MA, Geredeli C, Yildirim Sari N, Ozaslan E, Aytekin A, Tamer Elkiran E, Koca S, Dogan M, Turan N, Yuce O, Sevinc A, Ercelep O, Isikdogan A
    • Issue date: 2019 Sep-Oct
    • Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
    • Authors: Oruc Z, Kaplan MA, Geredeli C, Yildirim Sari N, Ozaslan E, Aytekin A, Tamer Elkiran E, Koca S, Dogan M, Turan N, Yuce O, Sevinc A, Ercelep O, Isikdogan A
    • Issue date: 2020 Mar-Apr
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.